18 mg tirzepatide FDA Grants a New Indication for Obesity Management Tirzepatide Injection At-Home

Skip aspiration for subcutaneous shots it isnt needed and can add discomfort [13]

It is not approved for weight loss

These conditions don't significantly affect how your body processes tirzepatide, unlike many medications that require careful dose adjustments based on organ function

Safety Considerations: Tirzepatide is not recommended for those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, a history of pancreatitis, or severe gastrointestinal disease

[19] [20] The FDA approved it for weight loss in November 2023

early results may be modest Muscle preservation Weight loss from tirzepatide, when combined with adequate protein intake and resistance exercise, can preserve lean muscle mass Without sufficient protein intake and activity, rapid weight loss on tirzepatide can lead to muscle loss alongside fat loss Mental health and mood Many patients report improved mood, confidence, and quality of life as weight loss progresses and energy levels improve Some patients report mood changes, increased anxiety, or low mood in the early adjustment period